Reducing Failed IV Attempts in Pediatric Patients: A Clinical Case for Vein Visualization

Peripheral IV insertion is one of the most common procedures in pediatric care — and one of the most reliably difficult. Pediatric patients present a unique combination of physiological and behavioral challenges that make standard visual assessment unreliable: veins are smaller, more mobile, and more deeply positioned relative to adult anatomy. Subcutaneous fat distribution varies significantly by age. And unlike adult patients, children cannot be coached to stay still when they're frightened.

The result is a procedural environment where failed IV attempts are not exceptional — they're expected. Nursing staff absorb this reality as part of the job. But the clinical and human costs accumulate across every shift, every unit, and every patient cohort that includes young children.

The question worth examining is not whether difficult IV access in pediatric patients is a problem. It clearly is. The more useful question is what evidence-based tools exist to change the outcome before the first attempt is made.

Why Pediatric IV Access Fails More Often

The physiology of pediatric venous access is distinct in ways that make standard technique less predictive of success. In neonates and infants, vein diameter is often under 2mm. In toddlers and young children, subcutaneous fat layers obscure even reasonably sized vessels. In adolescents, anxiety-driven vasoconstriction can collapse veins that were visible during assessment seconds earlier.

Standard visual and palpation-based assessment depends heavily on practitioner experience — and on patient cooperation that pediatric populations cannot reliably provide. Studies consistently show that first-stick success using standard of care in pediatric patients falls well below what's achievable with adjunct visualization.

Beyond the physiological challenges, there's the behavioral dimension. A child who has experienced one or more failed IV attempts approaches subsequent attempts with heightened fear responses. This creates a feedback loop: anxiety → vasoconstriction → failed access → heightened anxiety. Clinical staff recognize this pattern. Families experience it as a visible failure of care, regardless of the clinical context that caused it.

Multiple failed attempts also carry direct clinical risks: increased infection exposure, tissue trauma, and in time-critical presentations, delayed treatment. The stakes are not simply procedural.

What First-Stick Success Rates Actually Tell Us

Comparative data on vein visualization technology provides a useful benchmark. In peer-reviewed studies, first-stick success using standard visual assessment in pediatric populations ranges from approximately 50–72%. This reflects both the difficulty of the patient population and the inherent limitations of unassisted technique.

Transillumination-based vein visualization — which passes high-intensity LED light through the tissue to create contrast between veins and surrounding structures — produces measurably different results. Veinlite devices have demonstrated a 93% first-stick success rate in clinical use, compared to 72% with standard of care and 45% with infrared projection-based alternatives such as AccuVein.

That 21-percentage-point improvement over standard of care represents, in practical terms, a substantial reduction in the number of pediatric patients who experience a second or third IV attempt per admission. At scale — across a unit, a department, a health system — it represents tens of thousands of avoided failed attempts annually.

First-stick success is not only a patient experience metric. It is a clinical efficiency metric. It reduces supply consumption, nursing time per patient, escalation rates, and the downstream behavioral complications that make subsequent care more difficult.

Transillumination Technology: How It Works in Clinical Practice

Transillumination works on a different principle than infrared vein projection. Rather than casting an image of vein structure onto the skin surface (which can be difficult to interpret in real time, particularly in high-ambient-light environments), transillumination illuminates the tissue directly, making veins visible as darker channels against the backlit tissue.

This produces a visualization that is immediate, intuitive, and usable at the point of care without additional training curves. Nurses who adopt transillumination devices report that the learning period is short — the visual information mirrors the spatial reasoning already embedded in palpation-based assessment, with the added advantage of depth visualization that palpation cannot provide.

Importantly, transillumination performs consistently across skin tones. Infrared projection-based systems can produce less reliable contrast on darker skin tones due to melanin absorption differences. Transillumination is not affected by this variable, making it equitable across patient populations.

For pediatric applications specifically, device size and form factor matter. A device calibrated for adult anatomy will not produce the same focal precision on a two-year-old's forearm. Purpose-built pediatric vein finders apply appropriate aperture and light distribution for the scale of the patient — from neonates through adolescents.

Veinlite Devices for Pediatric and Neonatal Use

Two Veinlite devices are purpose-built for younger patient populations:

Veinlite PEDI2 — $249

Designed for pediatric patients from birth through age 17, the PEDI2 delivers transillumination calibrated for smaller-diameter vessels and variable subcutaneous depth. Lightweight, handheld, and FDA-registered. Suitable for bedside use in pediatric wards, infusion centers, urgent care, and home health settings. View PEDI2 →

Veinlite NEO — $299

Designed specifically for neonatal and NICU care, the NEO addresses the particular challenges of the smallest patients — premature infants, low-birth-weight neonates, and critically ill newborns where vein and artery access is both essential and technically demanding. View NEO →

Both devices are trusted by clinical teams across 100+ countries and work effectively across all skin tones.

Procurement teams evaluating vein visualization tools for pediatric units should consider the total cost analysis: device cost against the clinical time, supply consumption, and patient experience costs of multiple failed attempts per patient encounter.

The Standard of Care Is Improvable

Difficult IV access in pediatric patients is a persistent clinical challenge — but it is not an unsolvable one. The evidence supports a clear clinical conclusion: visualization before the first stick produces better outcomes than palpation and visual assessment alone.

For units that have not yet adopted vein visualization technology, the adoption curve is short and the return on clinical quality is measurable.

Ready to improve first-stick outcomes for your pediatric patients?

Explore Veinlite Devices at veinlite.com →

Questions about which device fits your unit's patient population? Contact the Veinlite clinical team.

Veinlite devices are FDA-registered and trusted by 150,000+ medical professionals in 100+ countries.